Opicapone Improved Parkinson’s Disease-related Sleep Disturbances: Findings from the Oasis Study
Opicapone Improved Parkinson’s Disease-related Sleep Disturbances: Findings from the Oasis Study

Miguel Gago, Raquel Costa, Miguel Fonseca, Joana Almeida, Helena Brigas, Ghazal Banisadr, José-Francisco Rocha, Joerg Holenz, Joaquim Ferreira

View Poster
Long-Term Follow-Up of Opicapone Use As Add-On to Levodopa in Parkinson’s Patients Without Motor Fluctuations: Findings From the EPSILON Study
Long-Term Follow-Up of Opicapone Use As Add-On to Levodopa in Parkinson’s Patients Without Motor Fluctuations: Findings From the EPSILON Study

Joaquim J. Ferreira, Olivier Rascol, Fabrizio Stocchi, Angelo Antonini, Paloma Lapuente, Guillermo Castilla-Fernández, Helena Brigas, Ghazal Banisadr, José-Francisco Rocha, Joerg Holenz, Werner Poewe

View Poster
Opicapone for the Treatment of Early Wearing-Off in Levodopa-Treated Parkinson’s Disease Patients
Opicapone for the Treatment of Early Wearing-Off in Levodopa-Treated Parkinson’s Disease Patients

Joaquim J. Ferreira1, Jee-Young Lee, Hyeo-il Ma, Beomseok Jeon, Werner Poewe, Angelo Antonini, Fabrizio Stocchi, Daniela M. Rodrigues, Stanley Fisher, Miguel M. Fonseca, José-Francisco Rocha, Guillermo Castilla-Fernández, Joerg Holenz, Olivier Rascol

View Poster
“Good On” Time and Reducing Dyskinesia
Comparative analysis of opicapone and entacapone in the management of motor fluctuations in patients with Parkinson’s disease, from clinical trials to healthcare resource usage

Daniel Kremens, Fahd Amjad, Sandeep Thakkar, Bita Naderi, Diogo Martins, José-Franciso Rocha, Ghazal Banisadr, Stanley Fisher

View Poster
Opicapone as first strategy for the treatment of wearing-off in Korean patients with Parkinson’s disease

Jee-Young Lee, Joaquim J. Ferreira, Hyeo-il Ma, José-Francisco Rocha, Beomseok Jeon, on behalf of Korean OGT_001 study investigators

View Poster
Evaluation of opicapone’s efficacy in Parkinson’s disease patients with motor fluctuations: phase III, randomized, double-blind, placebo- and active-controlled study (BIPARK I)

Joaquim Ferreira, Andrew Lees, Ana Santos, Roberto Pinto, Nelson Lopes, Teresa Nunes, Jose Rocha and Patrício Soares-da-Silva

View Poster
“Good On” Time and Reducing Dyskinesia
Effect of Opicapone and Entacapone on Early Morning-OFF Pattern in Parkinson’s Disease Patients with Motor Fluctuations

A. Videnovic, W. Poewe, A. Lees, J.J. Ferreira, O. Klepitskaya, R. Loureiro, D. Magalhaes, J.F. Rocha, P. Soares-da-Silva

View Poster
This website and the information contained herein is intended for use by U.S. residents only. Amneal Pharmaceuticals’ rights to promote, offer for sale, and sell ONGENTYS is limited to the U.S.
Under license from bial
Sign Up and Stay Connected
Sign up for the Expert Institute for Parkinson’s Disease newsletter subscription to receive product information, educational tools, resources, and more!
See more